Table: Cosmos Pharmaceutical -Q1 group results

Cosmos Pharmaceutical

11/10/2024 07:00

Oct 11 (Reuters)- 
             Cosmos Pharmaceutical Corp. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Aug 31, 2024        Aug 31, 2023     May 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            261.84              241.65          1.04 trln  
                 (+8.4 pct)          (+17.2 pct)      (+7.5 pct)  
  Operating         11.58                8.99            31.60    
                 (+28.8 pct)         (+1.0 pct)       (+0.3 pct)  
  Recurring         12.29                9.70            34.40    
                 (+26.7 pct)         (+0.8 pct)       (+0.3 pct)  
  Net                8.14                6.51            24.50    
                 (+25.1 pct)         (+0.4 pct)       (+0.2 pct)  
  EPS            102.74 yen           82.17 yen       309.12 yen  
  Ann Div                            120.00 yen        65.00 yen  
  -Q2 div                             60.00 yen        32.50 yen  
  -Q4 div                             60.00 yen        32.50 yen  
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T